Kelly Sprout
Psychiatry · Sandusky, OHNPI 1659422129
Payments from drug & device makers
Across 321 payments — averaging $16.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$911
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$851
- Johnson & Johnson$765
- Teva Pharmaceuticals USA, Inc.$621
- Otsuka America Pharmaceutical, Inc.$469
- Indivior Inc.$354
- plus $1K from 11 others
What the payments were for
- Food & beverage$5,04997%
- Education$1583%
- Gifts$30%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 49 | $911 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 45 | $851 |
| Johnson & Johnson | 51 | $765 |
| Teva Pharmaceuticals USA, Inc. | 38 | $621 |
| Otsuka America Pharmaceutical, Inc. | 31 | $469 |
| Indivior Inc. | 24 | $354 |
| Alkermes, Inc. | 20 | $349 |
| Lundbeck LLC | 14 | $233 |
| Neurocrine Biosciences, Inc. | 11 | $158 |
| E.r. Squibb & Sons, L.L.C. | 11 | $143 |
| Takeda Pharmaceuticals U.S.A., Inc. | 14 | $135 |
| Vanda Pharmaceuticals Inc. | 5 | $94 |
| Axsome Therapeutics, Inc. | 4 | $85 |
| Idorsia Pharmaceuticals US Inc | 1 | $14 |
| Sage Therapeutics, LLC | 1 | $14 |
| Shire North American Group Inc | 1 | $13 |
| Validus Pharmaceuticals LLC | 1 | $3 |
How this compares
$5,210 in reported general payments places this provider in the 85th percentile of 1,119 psychiatry providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Invega SustennaPaliperidone Palmitate | 221 | $685,307 |
| VraylarCariprazine Hcl | 186 | $277,455 |
| IngrezzaValbenazine Tosylate | 29 | $238,701 |
| CaplytaLumateperone Tosylate | 92 | $163,913 |
| Abilify MaintenaAripiprazole | 55 | $155,381 |
| Invega TrinzaPaliperidone Palmitate | 13 | $121,612 |
| RexultiBrexpiprazole | 37 | $63,311 |
| Aripiprazole | 496 | $53,047 |
| AristadaAripiprazole Lauroxil | 18 | $51,992 |
| Risperdal ConstaRisperidone Microspheres | 20 | $43,697 |
| Lurasidone Hcl | 144 | $39,802 |
| Paliperidone ErPaliperidone | 126 | $32,846 |
| FanaptIloperidone | 11 | $19,349 |
| Buspirone Hcl | 864 | $17,919 |
| SaphrisAsenapine Maleate | 14 | $16,709 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonInvega Sustenna, Invega Trinza, Risperdal Consta | $765 | $850,616254 claims |
| AbbVieVraylar, Saphris, Fetzima | $911 | $305,385223 claims |
| Neurocrine Biosciences, Inc.Ingrezza | $158 | $238,70129 claims |
| Otsuka America Pharmaceutical, Inc.Abilify Maintena, Rexulti | $469 | $218,69292 claims |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $851 | $163,91392 claims |
| Alkermes, Inc.Aristada | $349 | $51,99218 claims |
| Vanda Pharmaceuticals Inc.Fanapt | $94 | $19,34911 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $135 | $15,44930 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,119 psychiatry providers in Ohio.
Other psychiatry in Sandusky
- Shishuka MalhotraCanton$15M
- Henry NasrallahCincinnati$3.8M
- Otto DuenoDayton$3.1M
- Diab AlmhanaAvon Lake$2.7M
- Mohamed Abdel AzizWest Chester$2.6M
- Fred RomeoColumbus$2.3M
- Mark WoyshvilleMiddleburg Heights$2.2M
- Amita PatelDayton$2.1M
- Caleb AdlerCincinnati$2M
- Richard SandersDayton$1.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.